Vivakor Announces Completion of Independent Testing of Its VivaBlend Nutraceutical
CORALVILLE, Iowa-(Business Wire)-September 14, 2009 - Vivakor™, Inc. (OTCBB: VIVK) today announced the results of independent, third-party validation testing of its VivaBlend™ nutraceutical product. VivaBlend is a powerful extract developed by the scientists at Vivakor and is derived from over 18 highly bioactive fruits, vegetables and legumes. Through a proprietary formulation and extraction process, Vivakor scientists have maximized the health benefits of VivaBlend by creating an optimum blend of super-antioxidants and powerful plant phenolics and flavonoids. Dr. Tannin Fuja, Vivakor’s CEO & Chief Scientist, stated, “We are very pleased with the performance of VivaBlend in this independent testing. Many products can claim high levels of antioxidants, but these data confirm that VivaBlend contains high levels of bioactive antioxidants and phytochemicals from a balanced and diverse array of plant sources.” The results from this testing provides validation for some of the underlying claims of the VivaBlend product and Dr. Fuja indicated, “These results are expected to give VivaBlend an advantage in the multi-billion dollar antioxidant supplement market.” More information about VivaBlend can be found at www.vivakor.com.
Results from third-party testing show that VivaBlend contains an overall high level of antioxidants (97.06 μmol TE/ml). Published data indicate that, while beneficial, hydrophilic antioxidants, which are common in many products currently on the market, do not accumulate in the body and are rapidly excreted in the urine. Lipophilic antioxidants, which are a key component of VivaBlend, penetrate the lipoprotein cell membrane more easily and therefore reach a higher level of bioavailability. The results of the independent testing show that VivaBlend contains very high levels of bioavailable lipophilic antioxidants (5.21 μmol TE/ml). Comparing these results with those reported in the Journal of Agriculture and Food Chemistry for the popular antioxidant beverage, Mona Vie, VivaBlend contains 425% of the levels of total antioxidants and 850% of the levels of lipophilic antioxidants found in an equivalent volume of Mona Vie. In addition, results show that VivaBlend is rich in beneficial phytochemicals or plant polyphenols (7.05 mg/ml), which is over 475% of the total phenolics reported in Mona Vie. Data show that different plants have differing amounts and types of antioxidants and other beneficial compounds collectively called "phytochemicals," which may reduce the adverse effects of aging and may lessen the risk of developing a wide variety of chronic diseases (e.g. cancer, cardiovascular disease, immune-system decline, stroke, Alzheimer's disease, Parkinson's disease, diabetes, rheumatoid arthritis and cataracts).
Taking a mixture phytochemicals from multiple sources, such as those in VivaBlend, has been suggested to have a synergistic benefit beyond that of a single source or a single food group (e.g. fruits or berries). A balanced extract from a wide variety of phytochemical rich plants, like VivaBlend, with its organic compounds, is needed to work with your body’s natural defense system to properly address the risks of exposure to free radicals and prevent the oxidative stress to your immune system and body as a whole. Published studies also suggest that high dietary intake of a variety of fruits and vegetables offers greater health benefits than high intake of antioxidants from a single super-fruit or berry. Scientists are still discovering the benefits of these potent natural chemicals in improved health and wellness.
About Vivakor, Inc.
Vivakor is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. The R&D Core at Vivakor (the idea hub) innovates, develops and validates biomedical devices and biotechnologies. Commercialization of Vivakor technologies is accomplished through direct sales and through partnerships with manufacturers and niche-industry marketing and distribution leaders. Vivakor generates revenues through the licensing or sale of its technologies. Vivakor is also preparing a portfolio of intellectual properties and subsidiaries. The subsidiaries will focus on the commercialization of technologies developed by Vivakor. More information can be found about Vivakor at www.vivakor.com.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor’s VivaBlend product. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor’s filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
